Early Cancer Institute Seminar: Professor Nora Pashayan

Early Cancer Institute Seminar: Professor Nora Pashayan

Seminar presented by Professor Nora Pashayan: Could risk stratification improve breast cancer screening?

By Cancer Research UK Cambridge Centre

Date and time

Tue, 23 Apr 2024 12:30 - 14:00 GMT+1

Location

Early Cancer Institute, University of Cambridge

Adrian Way Cambridge CB2 0XZ United Kingdom

About this event

The seminar series from the Early Cancer Institute aims to connect researchers in the early cancer detection and diagnosis space to share knowledge and spark collaboration. Join fellow researchers for lunch and an opportunity to network.

On Tuesday 23rd April we welcome Nora Pashayan, Professor of the Epidemiology of Ageing, Department of Public Health and Primary Care, to give a talk: 'Could risk stratification improve breast cancer screening?'

This event will take place in the Early Cancer Institute, Adrian Way, Cambridge Biomedical Campus, Cambridge, CB2 0XZ

Lunch is provided from 12:30pm, the talk will begin at 1.00pm followed by a Q&A. Please ensure you arrive promptly.


Speaker Biography:

Nora Pashayan is a Professor of the Epidemiology of Ageing and honorary Consultant in Public Health Medicine at the University of Cambridge. She is a cancer epidemiologist, a clinician with specialties in both Family Medicine and Public Health Medicine, and the Director of Training for the International Alliance for Cancer Early Detection.

Until recently, she held the position of Professor of Applied Cancer Research and Head of the Department of Applied Health Research at the University College London. Her primary research field is risk-stratified cancer screening, from understanding disease course, evaluating screening strategies, to implementation of novel screening strategies.

Organised by

The Cancer Research UK Cambridge Centre unites over 1,000 world-leading biologists, chemists, physicists, engineers, mathematicians, computer scientists, clinicians, nurses and allied healthcare professionals from across Cambridge, UK to tackle cancer from every angle.

Our mission is to end death and disease caused by cancer through research, treatment and education. We are detecting cancer at its earliest stage and are developing personalised treatments for every patient through facilitating new collaborations and driving the translation of new scientific discoveries into clinical applications to improve patient care. By working together across a range of different disciplines, our members are breaking down the barriers between the laboratory and the clinic, enabling patients to benefit from the latest innovations in cancer science.

Sales Ended